Chandrasingh Jeyachandra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chandrasingh Jeyachandra has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Antony Devasia
Department of Urology, Christian Medical College, Vellore, Tamil Nadu, India
3 shared publications- Santosh Kumar
Christian Med Coll & Hosp, Dept Urol, Ranipet Campus, Kilminnal Village 632517, Tamil Nadu, India
3 shared publications Sudhindra Jayasimha
Department of Urology, Christian Medical College Vellore, Ranipet Campus, Ranipet, Tamil Nadu, India
3 shared publications- Sudhindra Jayasimha
Great Ormond Street Hospital for Children, Great Ormond Street, London WC1N 3JH, United Kingdom
3 shared publications - Arun Jacob Philip George
Department of Urology, Christian Medical College and Hospital, Vellore, India
2 shared publications Nitin S. Kekre
Christian Medical College
2 shared publications
Latest Publications
- Open Access
- 8 May 2026
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 42 (3) , 213-217
Is uroflow reproducible in healthy boys? A community-based observational study from Southern India
Introduction: This study evaluates the reproducibility of uroflowmetry in children aged 5-15 years to establish the age at which uroflowmetry is representative. Methods: Of 291 boys screened, uroflowmetry was done in 247 eligible boys. The flow was repeated at two weeks. A total of 227 children were included for analysis. Twenty were excluded due to a voided volume of less than 50ml and an interrupted flow pattern. The maximum flow rate (Qmax), average flow rate (Qavg), voided volume (VV), time to maximum flow, flow time and voiding time were recorded. The reproducibility of all parameters was assessed using the Inter-correlation coefficient (ICC) and correlation using Pearson’s coefficient. Result: Qmax, Qavg showed excellent concordance in boys of 5-15 years [ICC >0.6], implying the flows were reproducible. VV showed excellent concordance in boys aged 8-15 years [ICC >0.6], but only moderate correlation in boys aged 5-7 years [ICC 0.4-0.6], probably due to the wide variation in voided volumes. Qmax and Qavg showed significant correlation in all age groups, with voided volume in first and second flow [Pearson’s coefficient: 0.49 & 0.53 for Qmax1 and Qmax2; 0.48 & 0.51 Qavg1 and Qavg2 respectively], implying reproducibility of flow in this age group. Conclusion: Uroflowmetry is reproducible in children aged 5-15 years. Qmax and Qavg showed excellent reproducibility, and voided volume showed good reproducibility. Qmax shows excellent reproducibility even in the smallest of the age groups studied [5-7 years].
- 8 May 2026
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 42 (3) , 213-217
Open AccessIs uroflow reproducible in healthy boys? A community-based observational study from Southern India
Introduction: This study evaluates the reproducibility of uroflowmetry in children aged 5-15 years to establish the age at which uroflowmetry is representative. Methods: Of 291 boys screened, uroflowmetry was done in 247 eligible boys. The flow was repeated at two weeks. A total of 227 children were included for analysis. Twenty were excluded due to a voided volume of less than 50ml and an interrupted flow pattern. The maximum flow rate (Qmax), average flow rate (Qavg), voided volume (VV), time to maximum flow, flow time and voiding time were recorded. The reproducibility of all parameters was assessed using the Inter-correlation coefficient (ICC) and correlation using Pearson’s coefficient. Result: Qmax, Qavg showed excellent concordance in boys of 5-15 years [ICC >0.6], implying the flows were reproducible. VV showed excellent concordance in boys aged 8-15 years [ICC >0.6], but only moderate correlation in boys aged 5-7 years [ICC 0.4-0.6], probably due to the wide variation in voided volumes. Qmax and Qavg showed significant correlation in all age groups, with voided volume in first and second flow [Pearson’s coefficient: 0.49 & 0.53 for Qmax1 and Qmax2; 0.48 & 0.51 Qavg1 and Qavg2 respectively], implying reproducibility of flow in this age group. Conclusion: Uroflowmetry is reproducible in children aged 5-15 years. Qmax and Qavg showed excellent reproducibility, and voided volume showed good reproducibility. Qmax shows excellent reproducibility even in the smallest of the age groups studied [5-7 years].
- 7 March 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 20 (3) , 503.e1-503.e8
Pelvic fracture urethral injury in adolescents – Predictors of outcomes and surgical complexity
- 7 March 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 20 (3) , 503.e1-503.e8
Pelvic fracture urethral injury in adolescents – Predictors of outcomes and surgical complexity
- 10 March 2022
- Published by Springer Nature
- p. 389-399
Psychosocial, Sexual Function, and Fertility in Hypospadias
- 10 March 2022
- Published by Springer Nature
- p. 389-399
Psychosocial, Sexual Function, and Fertility in Hypospadias
- 1 June 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (3) , 399.e1-399.e7
Management of proximal migration of double-J stents after Anderson-Hynes pyeloplasty in children
- 1 June 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (3) , 399.e1-399.e7
Management of proximal migration of double-J stents after Anderson-Hynes pyeloplasty in children
- 13 April 2021
- Published by Springer Nature in International Urology and Nephrology
- Vol. 53 (8) , 1583-1589
Satisfaction and genital perception after orchiectomy for prostate cancer: does the technique matter? A randomized trial
Objectives Bilateral extracapsular or total orchiectomy (BEO) for prostate cancer is presumed to have psychological consequences after the surgery due to perception of an empty scrotum. Bilateral subcapsular orchiectomy (BSO) was designed to preserve perception of palpable testes. We compared the patients' satisfaction and genital perception following BEO and BSO. Materials and methods Prostate cancer patients eligible for androgen deprivation therapy who opted for orchiectomy were enrolled in prospective randomized study. Patients with bleeding disorder or uncorrected coagulopathy, poor performance score, and psychiatric problems were excluded. Outlook to life and own health in-general, overall satisfaction to the procedure and genital perception was evaluated using modified Fugl-Meyer questionnaire (FMQ) which was administered before and after 3 months of the surgery. Patients were randomized to BEO and BSO groups at the time of surgery using block randomization. Primary outcome was to compare the genital perception of testicular loss and patients’ satisfaction to BSO and BEO. Secondary outcomes included testosterone and PSA control, operative time, and complications. Results Total 35 patients were enrolled in each group which was comparable. There was no difference in PSA control at 3 months. Mean operative time and blood loss were significantly lesser in BEO group. FMQ score at 3 months did not show significant difference. Majority of the patients in both groups were satisfied with procedure and the aesthetic value of scrotum after surgery. However, 84% in BSO group did not feel that testes were removed on self-examination, as compared to 28% in BEO group. Majority patients in both groups did not report physical or psychological discomfort from change in scrotal content. Conclusions Results showed that patients’ satisfaction and genital perception following BSO and BEO were similar. Feeling of remaining intrascrotal contents after BSO did not had added psychological advantage in terms of perception of genitalia.
- 13 April 2021
- Published by Springer Nature in International Urology and Nephrology
- Vol. 53 (8) , 1583-1589
Satisfaction and genital perception after orchiectomy for prostate cancer: does the technique matter? A randomized trial
Objectives Bilateral extracapsular or total orchiectomy (BEO) for prostate cancer is presumed to have psychological consequences after the surgery due to perception of an empty scrotum. Bilateral subcapsular orchiectomy (BSO) was designed to preserve perception of palpable testes. We compared the patients' satisfaction and genital perception following BEO and BSO. Materials and methods Prostate cancer patients eligible for androgen deprivation therapy who opted for orchiectomy were enrolled in prospective randomized study. Patients with bleeding disorder or uncorrected coagulopathy, poor performance score, and psychiatric problems were excluded. Outlook to life and own health in-general, overall satisfaction to the procedure and genital perception was evaluated using modified Fugl-Meyer questionnaire (FMQ) which was administered before and after 3 months of the surgery. Patients were randomized to BEO and BSO groups at the time of surgery using block randomization. Primary outcome was to compare the genital perception of testicular loss and patients’ satisfaction to BSO and BEO. Secondary outcomes included testosterone and PSA control, operative time, and complications. Results Total 35 patients were enrolled in each group which was comparable. There was no difference in PSA control at 3 months. Mean operative time and blood loss were significantly lesser in BEO group. FMQ score at 3 months did not show significant difference. Majority of the patients in both groups were satisfied with procedure and the aesthetic value of scrotum after surgery. However, 84% in BSO group did not feel that testes were removed on self-examination, as compared to 28% in BEO group. Majority patients in both groups did not report physical or psychological discomfort from change in scrotal content. Conclusions Results showed that patients’ satisfaction and genital perception following BSO and BEO were similar. Feeling of remaining intrascrotal contents after BSO did not had added psychological advantage in terms of perception of genitalia.
- Open Access
- 1 April 2021
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 37 (2) , 133-139
Efficacy of 1 versus 3 days of intravenous amikacin as a prophylaxis for patients undergoing transurethral resection of the prostate: A prospective randomized trial
Introduction: There are no uniform guidelines on the duration of antibiotic prophylaxis for transurethral resection of the prostate (TURP). The objective of this study was to evaluate the efficacy of 1 day versus 3 days of intravenous amikacin as prophylaxis, before TURP. Materials and Methods: In this prospective randomized control trial, patients with sterile preoperative urine culture were randomized to receive either 1 day (Group A) or 3 days (Group B) of intravenous (IV) amikacin. All patients had their catheter removed on the 3 rd day and a midstream urine culture was obtained on the 4 th day. The follow-up was scheduled at 1 week and at 1 month. The rate of bacteriuria on the 4 th postoperative day was analyzed as the primary outcome. The secondary outcomes included symptomatic urinary tract infection (UTI), its risk factors, and other complications at 1 month. Results: Of the 338 patients randomized, 314 patients were evaluable until day 7 and 307 until 1 month. Bacteriuria rate at day 4 (Group A: 8.8% [95% confidence interval (CI): 4.2–13.2]; Group B: 4.4% [95% CI: 1.2%–7.7%], P = 0.124, Fisher's exact test) was similar in both the groups. At 1 month, the rate of symptomatic UTI was also similar in both the groups (3.5% [95% CI: 0.8–6.9] vs. 1.7% [95% CI: 0.2–4.2], P = 0.344, Fisher's exact test). Bacteriuria (colony-forming unit, >10 4 /ml) at day 4 was a significant risk factor for developing symptomatic UTI ( P = 0.006). Antibiotic resistance was higher in Group B ( P = 0.002) (Group A: 7.1% [95% CI: 6.3–20] vs. Group B: [71%, CI: 38–104], P = 0.0021, Fisher's exact test). Conclusion: One day is possibly noninferior to 3 days of IV amikacin as prophylaxis in patients undergoing TURP with respect to bacteriuria and symptomatic UTI, with an added advantage of lower antibiotic resistance.
- 1 April 2021
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 37 (2) , 133-139
Open AccessEfficacy of 1 versus 3 days of intravenous amikacin as a prophylaxis for patients undergoing transurethral resection of the prostate: A prospective randomized trial
Introduction: There are no uniform guidelines on the duration of antibiotic prophylaxis for transurethral resection of the prostate (TURP). The objective of this study was to evaluate the efficacy of 1 day versus 3 days of intravenous amikacin as prophylaxis, before TURP. Materials and Methods: In this prospective randomized control trial, patients with sterile preoperative urine culture were randomized to receive either 1 day (Group A) or 3 days (Group B) of intravenous (IV) amikacin. All patients had their catheter removed on the 3 rd day and a midstream urine culture was obtained on the 4 th day. The follow-up was scheduled at 1 week and at 1 month. The rate of bacteriuria on the 4 th postoperative day was analyzed as the primary outcome. The secondary outcomes included symptomatic urinary tract infection (UTI), its risk factors, and other complications at 1 month. Results: Of the 338 patients randomized, 314 patients were evaluable until day 7 and 307 until 1 month. Bacteriuria rate at day 4 (Group A: 8.8% [95% confidence interval (CI): 4.2–13.2]; Group B: 4.4% [95% CI: 1.2%–7.7%], P = 0.124, Fisher's exact test) was similar in both the groups. At 1 month, the rate of symptomatic UTI was also similar in both the groups (3.5% [95% CI: 0.8–6.9] vs. 1.7% [95% CI: 0.2–4.2], P = 0.344, Fisher's exact test). Bacteriuria (colony-forming unit, >10 4 /ml) at day 4 was a significant risk factor for developing symptomatic UTI ( P = 0.006). Antibiotic resistance was higher in Group B ( P = 0.002) (Group A: 7.1% [95% CI: 6.3–20] vs. Group B: [71%, CI: 38–104], P = 0.0021, Fisher's exact test). Conclusion: One day is possibly noninferior to 3 days of IV amikacin as prophylaxis in patients undergoing TURP with respect to bacteriuria and symptomatic UTI, with an added advantage of lower antibiotic resistance.
- 1 February 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (1) , 81
Response to commentary re ‘Extracorporeal shock wave lithotripsy in Indian children: Predictors of outcome and validation of pre-treatment nomograms'
- 1 February 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (1) , 81
Response to commentary re ‘Extracorporeal shock wave lithotripsy in Indian children: Predictors of outcome and validation of pre-treatment nomograms'
- 1 February 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (1) , 79.e1-79.e8
Extracorporeal shock wave lithotripsy in Indian children: Predictors of outcome and validation of pre-treatment nomograms
- 1 February 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (1) , 79.e1-79.e8
Extracorporeal shock wave lithotripsy in Indian children: Predictors of outcome and validation of pre-treatment nomograms
- Open Access
- 1 January 2016
- Published by Medknow in Indian Journal of Urology
- Vol. 32 (2) , 156-8
Urethral duplication with unusual cause of bladder outlet obstruction
Official publication of Urological Society of India.
- 1 January 2016
- Published by Medknow in Indian Journal of Urology
- Vol. 32 (2) , 156-8
Open AccessUrethral duplication with unusual cause of bladder outlet obstruction
Official publication of Urological Society of India.
- Open Access
- 25 May 2011
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 5 (1) , 205
Cutaneous Fusarium infection in a renal transplant recipient: a case report
Fungal infections in the immunocompromised host are fairly common. Of the mycoses, Fusarium species are an emerging threat. Fusarium infections have been reported in solid organ transplants, with three reports of the infection in patients who had received renal transplants. To the best of our knowledge, this is the first case of an isolated cutaneous lesion as the only form of infection.
- 25 May 2011
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 5 (1) , 205
Open AccessCutaneous Fusarium infection in a renal transplant recipient: a case report
Fungal infections in the immunocompromised host are fairly common. Of the mycoses, Fusarium species are an emerging threat. Fusarium infections have been reported in solid organ transplants, with three reports of the infection in patients who had received renal transplants. To the best of our knowledge, this is the first case of an isolated cutaneous lesion as the only form of infection.